Published in Eur Rev Med Pharmacol Sci on January 01, 2013
Lactulose Breath Test Gas Production in Childhood IBS is Associated with Intestinal Transit and Bowel Movement Frequency. J Pediatr Gastroenterol Nutr (2016) 0.75
Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet (2001) 3.28
Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol (2004) 2.55
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut (2009) 2.48
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. Ann Oncol (2007) 2.30
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
Screening test for coeliac disease. Lancet (1997) 2.23
Intestinal permeability in Crohn's disease patients and their first degree relatives. Dig Liver Dis (2001) 2.20
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis. J Thromb Haemost (2014) 2.15
Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol (1998) 1.83
The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol (1999) 1.76
Increased enterocyte apoptosis and Fas-Fas ligand system in celiac disease. Am J Clin Pathol (2001) 1.74
Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70
The incidence of coeliac disease in adult first degree relatives. Dig Liver Dis (2007) 1.69
Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut (1994) 1.57
Tissue transglutaminase antibodies for coeliac disease screening. Ital J Gastroenterol Hepatol (1998) 1.57
Plasma cytokine profiles in patients with celiac disease and selective IgA deficiency. Pediatr Allergy Immunol (2003) 1.55
Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut (2005) 1.55
Clinical features of coeliac disease. Dig Liver Dis (2002) 1.51
Quality control study of H2 breath testing for the diagnosis of carbohydrate malabsorption in Italy. The "Tenue Club" Group. Ital J Gastroenterol Hepatol (1997) 1.48
UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen. Oncology (2008) 1.43
Gluten sensitivity of small intestinal mucosa in vitro: quantitative assessment of histologic change. Gastroenterology (1981) 1.41
Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol (2000) 1.41
Endomysial and tissue transglutaminase antibodies in coeliac sera: a comparison not influenced by previous serological testing. Scand J Gastroenterol (2001) 1.39
Genetic test for lactase non-persistence and hydrogen breath test: is genotype better than phenotype to diagnose lactose malabsorption? Dig Liver Dis (2008) 1.39
Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease. Gut (2004) 1.38
DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease. Gut (1985) 1.35
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther (2004) 1.32
Quantitative assessment of the mucosal architecture of jejunal biopsy specimens: a comparison between linear measurement, stereology, and computer aided microscopy. J Clin Pathol (1985) 1.30
Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp (2007) 1.25
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut (2009) 1.22
Gluten specific suppressor T cell dysfunction in coeliac disease. Gut (1986) 1.17
Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol (2010) 1.16
Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol (2001) 1.16
Jejunal intraepithelial lymphocytes in coeliac disease: are they increased or decreased? Gut (1984) 1.15
Can antigliadin antibody detect symptomless coeliac disease in children with short stature? Lancet (1985) 1.14
Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut (1983) 1.12
Return of splenic function after splenectomy: how much tissue is needed? Br Med J (Clin Res Ed) (1984) 1.11
Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Work in progress. Radiology (1990) 1.11
Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2000) 1.11
Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis. Haemophilia (2008) 1.10
The immune recognition of gluten in coeliac disease. Clin Exp Immunol (2005) 1.10
Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther (2005) 1.10
Altered functional and structural connectivities in patients with MS: a 3-T study. Neurology (2007) 1.09
Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol (2001) 1.08
Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients. Eur Respir J (2002) 1.08
Immune reaction against the cytoskeleton in coeliac disease. Gut (2000) 1.07
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. Mucosal Immunol (2011) 1.04
Intraepithelial lymphocytes in the villous tip: do they indicate potential coeliac disease? J Clin Pathol (2004) 1.03
A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. J Antimicrob Chemother (1998) 1.02
Ageing and small-bowel mucosa: a morphometric study. Gerontology (1986) 1.02
The heme moiety of malaria pigment (beta-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-alpha production by lipopolysaccharide-stimulated macrophages. Exp Parasitol (1995) 1.00
Observer variation in assessment of jejunal biopsy specimens. A comparison between subjective criteria and morphometric measurement. Gastroenterology (1982) 1.00
Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms. Aliment Pharmacol Ther (2000) 1.00
Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann Hum Genet (2001) 0.99
Fasting breath hydrogen in celiac disease. Gastroenterology (1987) 0.97
Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Italian Herpes Forum. Sex Transm Dis (2000) 0.97
Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease, and enteropathy-associated T-cell. Scand J Gastroenterol (2000) 0.97
Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD). Clin Exp Immunol (2000) 0.97
Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment Pharmacol Ther (2004) 0.95
Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency. Am J Gastroenterol (2003) 0.95
A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 0.95
Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. Lancet (1989) 0.94
HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. J Clin Microbiol (2011) 0.94
Short stature and celiac disease: a relationship to consider even in patients with no gastrointestinal tract symptoms. J Pediatr (1983) 0.93
Coeliac Disease in the Elderly. A multicentre Italian study. Gerontology (2001) 0.93
Diffusion tensor magnetic resonance imaging at 3.0 tesla shows subtle cerebral grey matter abnormalities in patients with migraine. J Neurol Neurosurg Psychiatry (2006) 0.93
Splenic autotransplantation after splenectomy: tuftsin activity correlates with residual splenic function. Br J Surg (1994) 0.92
Coeliac disease. Dig Liver Dis (2002) 0.91
Antimicrobial use and resistance among Gram-negative bacilli in an Italian intensive care unit (ICU). J Chemother (2006) 0.91
Diagnostic value and biological significance of antibody-coated bacteria in urine. J Clin Pathol (1980) 0.91
Specificity of leucocyte migration inhibition test in coeliac disease. A reassessment using different gluten subfractions. Clin Exp Immunol (1985) 0.90
[Cryptococcus neoformans meningoencephalitis among apparently immunocompetent patients: description of two cases]. Infez Med (2009) 0.90
An automatic classification technique for attenuation correction in positron emission tomography. Eur J Nucl Med (1999) 0.90
Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study. Am J Gastroenterol (2004) 0.89
IgA antigliadin antibodies and persistence of jejunal lesions in adult coeliac disease. Digestion (1990) 0.89
Lactic dehydrogenase isoenzymes in urinary tract infections and aminoglycoside nephrotoxicity. Infection (1983) 0.89
Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study. Dig Dis Sci (1981) 0.89
Increased red cell distribution width and coeliac disease. Dig Liver Dis (2000) 0.88
A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation? Aliment Pharmacol Ther (1999) 0.88
Juxtapapillary pancreatic metastasis with obstructive jaundice as isolated recurrence of lung adenocarcinoma. Dig Liver Dis (2007) 0.88
Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther (2005) 0.87
Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents. Genes Chromosomes Cancer (1998) 0.87
Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin Exp Immunol (2003) 0.87
Asp57-negative HLA DQ beta chain and DQA1*0501 allele are essential for the onset of DQw2-positive and DQw2-negative coeliac disease. Clin Exp Immunol (1993) 0.87
The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy: a follow-up study. J Clin Pathol (2008) 0.87
Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut. Mucosal Immunol (2010) 0.86
Cerebellar signs in celiac disease. Neurology (2009) 0.86
Small bowel enterocyte apoptosis and proliferation are increased in the elderly. Gerontology (2002) 0.86
What will be the adult height of coeliac patients? Eur J Pediatr (1991) 0.86
[Epidemiology of reproductive tract infections in a symptomatic population of North-East of Italy]. Minerva Ginecol (2008) 0.86
Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J Neurol Neurosurg Psychiatry (2004) 0.86
Tissue transglutaminase antibodies in celiac disease. Am J Gastroenterol (1999) 0.85
Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. Ann Oncol (2008) 0.85